{
    "Trade/Device Name(s)": [
        "LIAISON PLEX Respiratory Flex Assay",
        "LIAISON PLEX\u00ae Respiratory Flex Assay",
        "LIAISON PLEX Respiratory Flex (RSP Flex) Assay"
    ],
    "Submitter Information": "Luminex Corporation",
    "510(k) Number": "K233410",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF",
        "OEM",
        "OOU",
        "OTG",
        "OZE",
        "OZX",
        "OZY",
        "OZZ",
        "OCC",
        "NSU"
    ],
    "Summary Letter Date": "October 6, 2023",
    "Summary Letter Received Date": "October 6, 2023",
    "Submission Date": "February 21, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "other"
    ],
    "Analyte(s)": [
        "Adenovirus",
        "Bordetella holmesii",
        "Bordetella parapertussis",
        "Bordetella pertussis",
        "Chlamydia pneumoniae",
        "Mycoplasma pneumoniae",
        "Human Coronavirus (HKU1, NL63, OC43, 229E not differentiated)",
        "Human Enterovirus/Rhinovirus (not differentiated)",
        "Human Metapneumovirus",
        "Influenza A",
        "Influenza A (subtype H1)",
        "Influenza A (subtype H3)",
        "Influenza B",
        "Parainfluenza 1",
        "Parainfluenza 2",
        "Parainfluenza 3",
        "Parainfluenza 4",
        "Respiratory Syncytial Virus",
        "Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab (NPS)"
    ],
    "Specimen Container(s)": [
        "Copan Universal Transport Medium",
        "BD Universal Viral Transport Media"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON PLEX System",
        "LIAISON PLEX Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcription",
        "Polymerase chain reaction (PCR)",
        "Multiplex PCR",
        "RT-PCR",
        "Array hybridization",
        "Microarray detection",
        "Nucleic acid extraction",
        "Magnetic bead-based nucleic acid isolation"
    ],
    "Methodologies": [
        "Qualitative multiplexed nucleic acid testing",
        "Molecular diagnostics",
        "PCR-based detection",
        "Reverse transcription PCR",
        "Array hybridization"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Instrument",
        "Software",
        "Reagent",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON PLEX Respiratory Flex Assay: qualitative multiplex PCR and array hybridization test for detection of bacterial and viral nucleic acids in nasopharyngeal swabs using the LIAISON PLEX System",
    "Indications for Use Summary": "Multiplexed qualitative test for simultaneous in vitro detection and identification of multiple bacterial and viral nucleic acids in nasopharyngeal swabs from individuals with clinical signs and symptoms of respiratory tract infection, including SARS-CoV-2, performed on the LIAISON PLEX System",
    "fda_folder": "Microbiology"
}